Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
The Italian pharmaceutical chemical maker Dipharma has struck a deal to acquire Kalexsyn, a Kalamazoo, Mich.-based provider of contract research services. Dipharma says the purchase will mesh Kalexsyn’s ability to carry out difficult syntheses of molecules for preclinical drug studies with its commercial manufacturing skills. Dipharma plans to install equipment allowing Kalexsyn to make larger volumes of molecules for clinical trials. Kalexsyn was formed in 2003 by two former Pfizer chemists.
This article has been sent to the following recipient: